Pharmaceutical Government Policy

Dykema can help clients formulate and execute efficient government policy strategies that get real world results. Our government policy lawyers and regulatory advisors offer guidance on state and national legislative matters that impact the pharmaceutical and medical device industry, as well as on such issues as government contracts, grants, research agreements, export control and technology transfers. 

Through our many years on Capitol Hill and working with many federal and state agencies, we have developed a deep and solid understanding of the inner workings of both federal and state governments, and formed close relationships with many high-ranking officials, lawmakers and staff. We maintain those relationships with integrity and credibility—which translates into substantial value to our clients.

Experience Matters

  • Represented a global healthcare supplier that develops, manufactures and distributes over-the-counter and prescription pharmaceuticals, nutritional products, and other consumer products in developing a strategy for, and writing and lobbying for passage in the Michigan legislature of, an amendment to Michigan’s version of the Unclaimed Property Act to provide for a business-to-business exception.
  • Represents clients in a wide array of product safety and liability, health, advertising and warranty, import and distribution, and related matters, including product recalls, agency investigations, agency rulemakings and resulting federal appellate court reviews.